Plain language summary of the INCREASE study: inhaled treprostinil (Tyvaso) for the treatment of pulmonary hypertension due to interstitial lung disease
Future Cardiology, Ahead of Print.
Source: Future Cardiology - Category: Cardiology Authors: Natalie West Karen Smoot Natalie Patzlaff Melissa Miceli Aaron Waxman Source Type: research
More News: Cardiology | Heart | Hypertension | Interstitial Lung Disease | Pulmonary Hypertension | Study